Radiofrequency Ablation for Dysplasia in Barrett's Esophagus Restores β-catenin Activation Within Esophageal Progenitor Cells

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2011 Sep 28

PMID 21948356

Citations 3

Authors

K Krishnan

S Komanduri

J Cluley

R Dirisina

P Sinh

Jeff Z Ko

L Li

R B Katzman

T A Barrett

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Endoscopic therapies for Barrett's esophagus (BE) associated dysplasia, particularly radiofrequency ablation (RFA), are popular alternatives to surgery. The effect of such therapies on dysplastic stem/progenitor cells (SPC) is unknown. Recent studies suggest that AKT phosphorylation of β-Catenin occurs in SPCs and may be a marker of activated SPCs. We evaluate the effect of RFA in restoring AKT-mediated β-Catenin signaling in regenerative epithelium.

Methods: Biopsies were taken from squamous, non-dysplastic BE, dysplastic BE and esophageal adenocarcinoma (EAC). Also, post-RFA, biopsies of endoscopically normal appearing neosquamous epithelium were taken at 3, 6, and 12 months after successful RFA. Immunohistochemistry and Western blot analysis was performed for Pβ-Catenin(552) (Akt-mediated phosphorylation of β-Catenin), Ki-67 and p53.

Results: There was no difference in Pβ-Catenin552 in squamous, GERD, small bowel and non-dysplastic BE. There was a fivefold increase in Pβ-Catenin(552) in dysplasia and EAC compared to non-dysplastic BE (P < 0.05). Also, there was a persistent threefold increase in Pβ-Catenin(552) in neosquamous epithelium 3 months after RFA compared to native squamous epithelium (P < 0.05) that correlated with increased Ki-67. Six months after RFA, Pβ-Catenin(552) and Ki-67 are similar to native squamous epithelium.

Conclusions: Enhanced AKT-mediated β-Catenin activation is seen in BE-associated carcinogenesis. Three months after RFA, squamous epithelial growth from SPC populations exhibited increased levels of Pβ-Catenin(552). This epithelial response becomes quiescent at 6 months after RFA. These data suggest that elevated Pβ-Catenin(552) after RFA denotes a repair response in the neosquamous epithelium 3 months post-RFA.

Citing Articles

The impact of flexible endoscopy in esophageal surgery.

Nieponice A, Nachman F, Badaloni A, Ciotola F, Zubieta C, Ramirez M J Thorac Dis. 2017; 9(Suppl 8):S681-S688.

PMID: 28815063 PMC: 5538993. DOI: 10.21037/jtd.2017.05.61.

Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma.

Levert-Mignon A, Bourke M, Lord S, Taylor A, Wettstein A, Edwards M United European Gastroenterol J. 2017; 5(1):13-20.

PMID: 28405317 PMC: 5384557. DOI: 10.1177/2050640616650794.

Management of early-stage esophageal neoplasia (MESEN) consensus.

Nieponice A, Badaloni A, Jobe B, Hoppo T, Pellegrini C, Velanovich V World J Surg. 2013; 38(1):96-105.

PMID: 24101017 DOI: 10.1007/s00268-013-2235-y.

References

Marsh V, Winton D, Williams G, Dubois N, Trumpp A, Sansom O . Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Nat Genet. 2008; 40(12):1436-44. DOI: 10.1038/ng.256. View

Sharma V, Jae Kim H, Das A, Dean P, Depetris G, Fleischer D . A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 2008; 40(5):380-7. DOI: 10.1055/s-2007-995587. View

Brown J, Lee G, Managlia E, Grimm G, Dirisina R, Goretsky T . Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. Gastroenterology. 2009; 138(2):595-605, 605.e1-3. PMC: 2819654. DOI: 10.1053/j.gastro.2009.10.038. View

Bian Y, Osterheld M, Bosman F, Fontolliet C, Benhattar J . Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus. Am J Clin Pathol. 2000; 114(4):583-90. DOI: 10.1309/3QLC-5MF1-JYXU-A5XX. View

Clement G, Braunschweig R, Pasquier N, Bosman F, Benhattar J . Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene. 2006; 25(21):3084-92. DOI: 10.1038/sj.onc.1209338. View

Morin P, Sparks A, Korinek V, Barker N, Clevers H, Vogelstein B . Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997; 275(5307):1787-90. DOI: 10.1126/science.275.5307.1787. View

Sansom O, Reed K, Hayes A, Ireland H, Brinkmann H, Newton I . Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 2004; 18(12):1385-90. PMC: 423189. DOI: 10.1101/gad.287404. View

Odze R, Lauwers G . Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy. 2008; 40(12):1008-15. DOI: 10.1055/s-0028-1103416. View

Flejou J . Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut. 2005; 54 Suppl 1:i6-12. PMC: 1867794. DOI: 10.1136/gut.2004.041525. View

10.

Reya T, Clevers H . Wnt signalling in stem cells and cancer. Nature. 2005; 434(7035):843-50. DOI: 10.1038/nature03319. View

11.

Lee G, Goretsky T, Managlia E, Dirisina R, Singh A, Brown J . Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology. 2010; 139(3):869-81, 881.e1-9. PMC: 2930080. DOI: 10.1053/j.gastro.2010.05.037. View

12.

Veeramachaneni N, Kubokura H, Lin L, Pippin J, Patterson G, Drebin J . Down-regulation of beta catenin inhibits the growth of esophageal carcinoma cells. J Thorac Cardiovasc Surg. 2004; 127(1):92-8. DOI: 10.1016/j.jtcvs.2003.06.008. View

13.

Shaheen N, Sharma P, Overholt B, Wolfsen H, Sampliner R, Wang K . Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009; 360(22):2277-88. DOI: 10.1056/NEJMoa0808145. View

14.

Birkmeyer J, Siewers A, Finlayson E, Stukel T, Lucas F, Batista I . Hospital volume and surgical mortality in the United States. N Engl J Med. 2002; 346(15):1128-37. DOI: 10.1056/NEJMsa012337. View

15.

Sharma P, Wani S, Rastogi A . Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both?. Gastrointest Endosc. 2007; 66(3):469-74. DOI: 10.1016/j.gie.2007.05.009. View

16.

Clevers H . Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127(3):469-80. DOI: 10.1016/j.cell.2006.10.018. View

17.

Gonzalez M, Artimez M, Rodrigo L, Lopez-Larrea C, Menendez M, Alvarez V . Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol. 1997; 50(3):212-7. PMC: 499815. DOI: 10.1136/jcp.50.3.212. View

18.

Sagatys E, Garrett C, Boulware D, Kelley S, Malafa M, Cheng J . Activation of the serine/threonine protein kinase Akt during the progression of Barrett neoplasia. Hum Pathol. 2007; 38(10):1526-31. DOI: 10.1016/j.humpath.2007.03.003. View

19.

Pouw R, Gondrie J, Sondermeijer C, Ten Kate F, van Gulik T, Krishnadath K . Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg. 2008; 12(10):1627-36. DOI: 10.1007/s11605-008-0629-1. View

20.

Pouw R, Gondrie J, Rygiel A, Sondermeijer C, Ten Kate F, Odze R . Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol. 2009; 104(6):1366-73. DOI: 10.1038/ajg.2009.88. View